“…Sex differences in the distribution of ERs (Bourque et al, 2011), together with a different role of ER subtypes in brain plasticity, neuroprotection and repair in male and female neurons (Bryant and Dorsa, 2010; may participate in the generation of sex differences in the neuroprotective actions of estradiol. In addition, there are differences in ER signaling in the brain of males and females (Tabatadze et al, 2015;Oberlander and Woolley, 2016;Koss et al, 2018;Jain et al, 2019;Meitzen et al, 2019;Zafer et al, 2019), which are in part mediated by epigenetic modifications in ER encoding genes (Schwarz et al, 2010;Giatti et al, 2018) and micro RNAs (Giatti et al, 2018) and are also dependent on sexually differentiated interactions with the signaling mechanisms of other neuroprotective factors, such as BDNF (Scharfman and MacLusky, 2014), IGF-1 (Munive et al, 2016) or the endocannabinoid system (Tabatadze et al, 2015), which in turn also present sex differences in the brain. All these sexually differentiated molecular mechanisms cause different responses to estradiol in the brain of male and female animals (Tabatadze et al, 2015;Munive et al, 2016;Koss et al, 2018) and may determine sex differences in the neuroprotective actions of the hormone.…”